Inventor
SHAILUBHAI KUNWAR
US51 patents
⚠️ This page may combine multiple inventors who share the name “SHAILUBHAI KUNWAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SYNERGY PHARMACEUTICALS INC
28 patentsUS8367800B2Feb 5, 2013
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
SYNERGY PHARMACEUTICALS INC40 citations98
US8357775B2Jan 22, 2013
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
SYNERGY PHARMACEUTICALS INC37 citations98
US7879802B2Feb 1, 2011
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
SYNERGY PHARMACEUTICALS INC47 citations98
US7041786B2May 9, 2006
Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
SYNERGY PHARMACEUTICALS INC102 citations98
US8034782B2Oct 11, 2011
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
SYNERGY PHARMACEUTICALS INC42 citations96
US7799897B2Sep 21, 2010
Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
SYNERGY PHARMACEUTICALS INC44 citations95
US8664354B2Mar 4, 2014
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
SYNERGY PHARMACEUTICALS INC17 citations93
US8569246B2Oct 29, 2013
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
SYNERGY PHARMACEUTICALS INC25 citations93
US9266926B2Feb 23, 2016
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
SYNERGY PHARMACEUTICALS INC14 citations92
US9238677B2Jan 19, 2016
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
SYNERGY PHARMACEUTICALS INC14 citations92
US8901075B2Dec 2, 2014
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
SYNERGY PHARMACEUTICALS INC16 citations92
US8497348B2Jul 30, 2013
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
SYNERGY PHARMACEUTICALS INC28 citations92
US9914752B2Mar 13, 2018
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
SYNERGY PHARMACEUTICALS INC5 citations84
US9814752B2Nov 14, 2017
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
SYNERGY PHARMACEUTICALS INC4 citations84
US9708367B2Jul 18, 2017
Agonists of guanylate cyclase and their uses
SYNERGY PHARMACEUTICALS INC5 citations84
US9505805B2Nov 29, 2016
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
SYNERGY PHARMACEUTICALS INC7 citations84
US9486494B2Nov 8, 2016
Compositions useful for the treatment of gastrointestinal disorders
SYNERGY PHARMACEUTICALS INC7 citations84
US10011637B2Jul 3, 2018
Ultra-pure agonists of guanylate cyclase C, method of making and using same
SYNERGY PHARMACEUTICALS INC8 citations83
US9610321B2Apr 4, 2017
Formulations of guanylate cyclase C agonists and methods of use
SYNERGY PHARMACEUTICALS INC4 citations83
US9545446B2Jan 17, 2017
Agonists of guanylate cyclase and their uses
SYNERGY PHARMACEUTICALS INC6 citations80
US10238712B2Mar 26, 2019
Compositions useful for the treatment of gastrointestinal disorders
SYNERGY PHARMACEUTICALS INC2 citations73
US9920095B2Mar 20, 2018
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
SYNERGY PHARMACEUTICALS INC5 citations73
US10232011B2Mar 19, 2019
Formulations of guanylate cyclase C agonists and methods of use
SYNERGY PHARMACEUTICALS INC2 citations72
US10034836B2Jul 31, 2018
Formulations of guanylate cyclase C agonists and methods of use
SYNERGY PHARMACEUTICALS INC2 citations72
US10342848B2Jul 9, 2019
Agonists of guanylate cyclase and their uses
SYNERGY PHARMACEUTICALS INC1 citations69
US10118946B2Nov 6, 2018
Agonists of guanylate cyclase and their uses
SYNERGY PHARMACEUTICALS INC1 citations63
US9925231B2Mar 27, 2018
Formulations of guanylate cyclase C agonists and methods of use
SYNERGY PHARMACEUTICALS INC0 citations51
US9919024B2Mar 20, 2018
Formulations of guanylate cyclase C agonists and methods of use
SYNERGY PHARMACEUTICALS INC0 citations51
BAUSCH HEALTH IRELAND LTD
10 patentsUS11319346B2May 3, 2022
Ultra-pure agonists of guanylate cyclase C, method of making and using same
BAUSCH HEALTH IRELAND LTD3 citations83
US11142549B2Oct 12, 2021
Ultra-pure agonists of guanylate cyclase C, method of making and using same
BAUSCH HEALTH IRELAND LTD3 citations83
US10745441B2Aug 18, 2020
Ultra-pure agonists of guanylate cyclase C, method of making and using same
BAUSCH HEALTH IRELAND LTD5 citations83
US10597424B2Mar 24, 2020
Agonists of guanylate cyclase and their uses
BAUSCH HEALTH IRELAND LTD1 citations73
US11834521B2Dec 5, 2023
Ultra-pure agonists of guanylate cyclase C, method of making and using same
BAUSCH HEALTH IRELAND LTD1 citations72
US10421787B2Sep 24, 2019
Process of preparing guanylate cyclase C agonisys
BAUSCH HEALTH IRELAND LTD3 citations69
US12146003B2Nov 19, 2024
Ultra-pure agonists of guanylate cyclase C, method of making and using same
BAUSCH HEALTH IRELAND LTD0 citations61
US10967043B2Apr 6, 2021
Agonists of guanylate cyclase and their uses
BAUSCH HEALTH IRELAND LTD0 citations59
US10711038B2Jul 14, 2020
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
BAUSCH HEALTH IRELAND LTD0 citations52
US10653744B2May 19, 2020
Formulations and methods for treating ulcerative colitis
BAUSCH HEALTH IRELAND LTD0 citations52
SHAILUBHAI KUNWAR
6 patentsUS8716224B2May 6, 2014
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
SHAILUBHAI KUNWAR31 citations96
US8114831B2Feb 14, 2012
Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
SHAILUBHAI KUNWAR37 citations95
US9089612B2Jul 28, 2015
Method of inhibiting bile acid absorption by administering an agonist of a guanylate cyclase receptor
SHAILUBHAI KUNWAR21 citations92
US8969514B2Mar 3, 2015
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
SHAILUBHAI KUNWAR25 citations92
US8207295B2Jun 26, 2012
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
SHAILUBHAI KUNWAR32 citations92
US8637451B2Jan 28, 2014
Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
SHAILUBHAI KUNWAR27 citations91
TIZIANA LIFE SCIENCES PLC
4 patentsUS10688186B2Jun 23, 2020
Anti-CD3 antibody formulations
TIZIANA LIFE SCIENCES PLC7 citations83
US11975111B2May 7, 2024
Dactinomycin compositions and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemia
TIZIANA LIFE SCIENCES PLC0 citations61
US10973773B2Apr 13, 2021
Dactinomycin compositions and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemia
TIZIANA LIFE SCIENCES PLC1 citations61
US10758541B2Sep 1, 2020
Formulations of milciclib and therapeutic combinations of the same for use in the treatment of cancer
TIZIANA LIFE SCIENCES PLC0 citations51
COMISKEY STEPHEN
1 patentBAI JUNCAI
1 patentShowing the top 50 of 51 patents by PatentIndex Score.